| Year |
Citation |
Score |
| 2001 |
Nechiporuk T, Urness LD, Keating MT. ETL, a novel seven-transmembrane receptor that is developmentally regulated in the heart. ETL is a member of the secretin family and belongs to the epidermal growth factor-seven-transmembrane subfamily. The Journal of Biological Chemistry. 276: 4150-7. PMID 11050079 DOI: 10.1074/Jbc.M004814200 |
0.52 |
|
| 1998 |
Nechiporuk T, Huynh DP, Figueroa K, Sahba S, Nechiporuk A, Pulst SM. The mouse SCA2 gene: cDNA sequence, alternative splicing and protein expression. Human Molecular Genetics. 7: 1301-9. PMID 9668173 DOI: 10.1093/Hmg/7.8.1301 |
0.6 |
|
| 1998 |
Sahba S, Nechiporuk A, Figueroa KP, Nechiporuk T, Pulst SM. Genomic structure of the human gene for spinocerebellar ataxia type 2 (SCA2) on chromosome 12q24.1. Genomics. 47: 359-64. PMID 9480749 DOI: 10.1006/Geno.1997.5131 |
0.646 |
|
| 1997 |
Nechiporuk T, Nechiporuk A, Sahba S, Figueroa K, Shibata H, Chen XN, Korenberg JR, de Jong P, Pulst SM. A high-resolution PAC and BAC map of the SCA2 region. Genomics. 44: 321-9. PMID 9325053 DOI: 10.1006/Geno.1997.4886 |
0.674 |
|
| 1996 |
Pulst SM, Nechiporuk A, Nechiporuk T, Gispert S, Chen XN, Lopes-Cendes I, Pearlman S, Starkman S, Orozco-Diaz G, Lunkes A, DeJong P, Rouleau GA, Auburger G, Korenberg JR, Figueroa C, et al. Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nature Genetics. 14: 269-76. PMID 8896555 DOI: 10.1038/Ng1196-269 |
0.665 |
|
| 1996 |
Nechiporuk T, Nechiporuk A, Guan X, Frederick R, Figueroa K, Chumakov I, Korenberg JR, de Jong PJ, Pulst SM. Identification of three new microsatellite markers in the spinocerebellar ataxia type 2 (SCA2) region and 1.2 Mb physical map. Human Genetics. 97: 462-7. PMID 8834243 DOI: 10.1007/Bf02267067 |
0.642 |
|
| 1996 |
Nechiporuk A, Lopes-Cendes I, Nechiporuk T, Starkman S, Andermann E, Rouleau GA, Weissenbach JS, Kort E, Pulst SM. Genetic mapping of the spinocerebellar ataxia type 2 gene on human chromosome 12. Neurology. 46: 1731-5. PMID 8649579 DOI: 10.1212/Wnl.46.6.1731 |
0.638 |
|
| 1994 |
Huynh DP, Nechiporuk T, Pulst SM. Alternative transcripts in the mouse neurofibromatosis type 2 (NF2) gene are conserved and code for schwannomins with distinct C-terminal domains. Human Molecular Genetics. 3: 1075-9. PMID 7981675 DOI: 10.1093/Hmg/3.7.1075 |
0.324 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2016 |
Nechiporuk T, McGann J, Mullendorff K, Hsieh J, Wurst W, Floss T, Mandel G. The REST remodeling complex protects genomic integrity during embryonic neurogenesis. Elife. 5. PMID 26745185 DOI: 10.7554/Elife.09584 |
0.282 |
|
| 1996 |
Huynh DP, Tran TM, Nechiporuk T, Pulst SM. Expression of neurofibromatosis 2 transcript and gene product during mouse fetal development. Cell Growth & Differentiation : the Molecular Biology Journal of the American Association For Cancer Research. 7: 1551-61. PMID 8930405 |
0.226 |
|
| 2014 |
Yao H, Goldman DC, Nechiporuk T, Kawane S, McWeeney SK, Tyner JW, Fan G, Kerenyi MA, Orkin SH, Fleming WH, Mandel G. Corepressor Rcor1 is essential for murine erythropoiesis. Blood. 123: 3175-84. PMID 24652990 DOI: 10.1182/Blood-2013-11-538678 |
0.223 |
|
| 2014 |
Cargnin F, Nechiporuk T, Müllendorff K, Stumpo DJ, Blackshear PJ, Ballas N, Mandel G. An RNA binding protein promotes axonal integrity in peripheral neurons by destabilizing REST. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 16650-61. PMID 25505318 DOI: 10.1523/Jneurosci.1650-14.2014 |
0.188 |
|
| 2016 |
Zhang D, Wu B, Wang P, Wang Y, Lu P, Nechiporuk T, Floss T, Greally JM, Zheng D, Zhou B. Non-CpG methylation by DNMT3B facilitates REST binding and gene silencing in developing mouse hearts. Nucleic Acids Research. PMID 27956497 DOI: 10.1093/Nar/Gkw1258 |
0.178 |
|
| 2017 |
Monaghan CE, Nechiporuk T, Jeng S, McWeeney SK, Wang J, Rosenfeld MG, Mandel G. REST corepressors RCOR1 and RCOR2 and the repressor INSM1 regulate the proliferation-differentiation balance in the developing brain. Proceedings of the National Academy of Sciences of the United States of America. PMID 28049845 DOI: 10.1073/Pnas.1620230114 |
0.148 |
|
| 2019 |
Nechiporuk T, Kurtz SE, Nikolova O, Liu T, Jones CL, D'Alessandro A, Culp-Hill R, d'Almeida A, Joshi SK, Rosenberg M, Tognon CE, Danilov AV, Druker BJ, Chang BH, McWeeney SK, et al. The TP53 Apoptotic Network is a Primary Mediator of Resistance to BCL2 inhibition in AML Cells. Cancer Discovery. PMID 31048320 DOI: 10.1158/2159-8290.Cd-19-0125 |
0.137 |
|
| 2019 |
Zhang H, Savage S, Schultz AR, Bottomly D, White L, Segerdell E, Wilmot B, McWeeney SK, Eide CA, Nechiporuk T, Carlos A, Henson R, Lin C, Searles R, Ho H, et al. Clinical resistance to crenolanib in acute myeloid leukemia due to diverse molecular mechanisms. Nature Communications. 10: 244. PMID 30651561 DOI: 10.1038/S41467-018-08263-X |
0.133 |
|
| 1994 |
Huynh DP, Nechiporuk T, Pulst SM. Differential expression and tissue distribution of type I and type II neurofibromins during mouse fetal development. Developmental Biology. 161: 538-51. PMID 8314000 DOI: 10.1006/Dbio.1994.1052 |
0.132 |
|
| 2019 |
Nechiporuk T, Damnernsawad A, Bottomly D, Morrow Q, Choi S, Beer S, Kurtz SE, McWeeney SK, Tyner JW. Genome-Wide CRISPR Screening in Acute Myeloid Leukemia Cells Identifies Genes in the PI3K/AKT/mTOR and MEK/ERK Pathways That Define Sensitivity to Trametinib Blood. 134: 1395-1395. DOI: 10.1182/Blood-2019-129117 |
0.11 |
|
| 2021 |
Romine KA, Nechiporuk T, Bottomly D, Jeng S, McWeeney SK, Kaempf A, Corces MR, Majeti R, Tyner JW. Monocytic differentiation and AHR signaling as Primary Nodes of BET Inhibitor Response in Acute Myeloid Leukemia. Blood Cancer Discovery. 2: 518-531. PMID 34568834 DOI: 10.1158/2643-3230.bcd-21-0012 |
0.108 |
|
| 2019 |
Damnernsawad A, Nechiporuk T, Bottomly D, Kurtz SE, Eide CA, McWeeney SK, Tyner JW. Genome-Wide CRISPR Screening Identifies MAPK and Mtorc Pathways As Regulators of Sorafenib Resistance in Acute Myeloid Leukemia Blood. 134: 2557-2557. DOI: 10.1182/Blood-2019-128877 |
0.098 |
|
| 2023 |
Eide CA, Kurtz SE, Kaempf A, Long N, Joshi SK, Nechiporuk T, Huang A, Dibb CA, Taylor A, Bottomly D, McWeeney SK, Minnier J, Lachowiez CA, Saultz JN, Swords RT, et al. Clinical Correlates of Venetoclax-based Combination Sensitivities to Augment Acute Myeloid Leukemia Therapy. Blood Cancer Discovery. PMID 37698624 DOI: 10.1158/2643-3230.BCD-23-0014 |
0.088 |
|
| 2022 |
Thieme E, Liu T, Bruss N, Roleder C, Lam V, Wang X, Nechiporuk T, Shouse G, Danilova OV, Bottomly D, McWeeney SK, Tyner JW, Kurtz SE, Danilov AV. Dual BTK/SYK inhibition with CG-806 (luxeptinib) disrupts B-cell receptor and Bcl-2 signaling networks in mantle cell lymphoma. Cell Death & Disease. 13: 246. PMID 35296646 DOI: 10.1038/s41419-022-04684-1 |
0.08 |
|
| 2020 |
Damnernsawad A, Bottomly D, Kurtz SE, Eide CA, McWeeney SK, Tyner JW, Nechiporuk T. Genome-wide CRISPR screen identifies regulators of MAPK and MTOR pathways mediating sorafenib resistance in acute myeloid leukemia. Haematologica. PMID 33375770 DOI: 10.3324/haematol.2020.257964 |
0.079 |
|
| 2021 |
Joshi SK, Nechiporuk T, Bottomly D, Piehowski PD, Reisz JA, Pittsenbarger J, Kaempf A, Gosline SJC, Wang YT, Hansen JR, Gritsenko MA, Hutchinson C, Weitz KK, Moon J, Cendali F, et al. The AML microenvironment catalyzes a stepwise evolution to gilteritinib resistance. Cancer Cell. PMID 34171263 DOI: 10.1016/j.ccell.2021.06.003 |
0.075 |
|
| 2021 |
Joshi SK, Nechiporuk T, Bottomly D, Piehowski PD, Reisz JA, Pittsenbarger J, Kaempf A, Gosline SJC, Wang YT, Hansen JR, Gritsenko MA, Hutchinson C, Weitz KK, Moon J, Cendali F, et al. The AML microenvironment catalyzes a stepwise evolution to gilteritinib resistance. Cancer Cell. PMID 34171263 DOI: 10.1016/j.ccell.2021.06.003 |
0.075 |
|
| 2007 |
Nechiporuk T, Fernandez TE, Vasioukhin V. Failure of epithelial tube maintenance causes hydrocephalus and renal cysts in Dlg5-/- mice. Developmental Cell. 13: 338-50. PMID 17765678 DOI: 10.1016/j.devcel.2007.07.017 |
0.052 |
|
| 2006 |
Nechiporuk T, Vasioukhin V. Planar cell polarity planes the inconveniences of cell division into a smooth morphogenetic process. Developmental Cell. 10: 153-4. PMID 16459292 DOI: 10.1016/J.Devcel.2006.01.004 |
0.049 |
|
| 2013 |
Nechiporuk T, Klezovitch O, Nguyen L, Vasioukhin V. Dlg5 maintains apical aPKC and regulates progenitor differentiation during lung morphogenesis. Developmental Biology. 377: 375-84. PMID 23466739 DOI: 10.1016/j.ydbio.2013.02.019 |
0.049 |
|
| 1981 |
Nechiporuk TS, Nosova LI, Parkhomets TI, Vasil'ev AN, Kucherenko NE. [Action of hydrazine sulfate on rat liver plasma membranes]. T͡Sitologii͡a I Genetika. 15: 13-7. PMID 7210177 |
0.044 |
|
| 2024 |
Modak RV, de Oliveira Rebola KG, McClatchy J, Mohammadhosseini M, Damnernsawad A, Kurtz SE, Eide CA, Wu G, Laderas T, Nechiporuk T, Gritsenko MA, Hansen JR, Hutchinson C, Gosline SJC, Piehowski P, et al. Targeting CCL2/CCR2 signaling overcomes MEK inhibitor resistance in Acute Myeloid Leukemia. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 38451486 DOI: 10.1158/1078-0432.CCR-23-2654 |
0.043 |
|
| 1980 |
Nechiporuk TS, Vasil'ev AN, Parkhomets TI. [Effect of hydrazine sulfate on lipid composition in rat liver homogenates and plasma membranes]. Ukrainskiĭ Biokhimicheskiĭ Zhurnal (1978). 52: 636-42. PMID 7256930 |
0.039 |
|
| Hide low-probability matches. |